Tropic Biosciences logo

Tropic Biosciences

Startups icon Seedtable Score 46 Startups icon Startups

2

Funding Rounds

1

Investors

$63.5m

Money raised

Overview

Tropic Biosciences, based in London, aims to transform the agricultural sector by developing high-yield tropical crop varieties using advanced genetic technologies. Their B2B model targets companies seeking to enhance agricultural productivity, addressing issues like lower yields, food insecurity, and slow crop adaptation to climate change. By focusing on high-value tropical crops, they position themselves advantageously against traditional breeding methods. Supported by Future Planet Capital, Tropic Biosciences is poised to leverage its tech expertise to deliver sustainable solutions needed in a changing world.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Investors (1)

Future Planet Capital logo Future Planet Capital

Data science, Database Software, Manufacturing, Health Tech, Open source, ...

Details

View all investors.

Join 23,000+ founders, operators and investors.

Funding

Funding series

Funding Series Analysis

The company Tropic Biosciences has raised a total of $63.5m in funding over 2 rounds.

Key Insights:

  • Series C: $35m
  • Series B: $28.5m
Tropic Biosciences logo
Tropic Biosciences Series B (2020, $28M) $28.5m
Tropic Biosciences logo
Tropic Biosciences Series C (2022, $35M) $35m